Vivos Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CONNECTIVE CAPITAL MANAGEMENT, LLC | 11/17/2025 | 200.00 K | $620.00 K | 100.00% | 2.20% |
| STRATEGIC WEALTH INVESTMENT GROUP, LLC | 11/14/2025 | 100.00 K | $310.00 K | 100.00% | 1.10% |
| VANGUARD GROUP INC | 11/07/2025 | 91.46 K | $283.53 K | 114.53% | 1.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 53.29 K | $165.20 K | -7.97% | 0.59% |
| B. RILEY WEALTH ADVISORS, INC. | 10/31/2025 | 43.53 K | $134.95 K | -37.39% | 0.48% |
| DRW SECURITIES, LLC | 11/14/2025 | 41.47 K | $128.54 K | 100.00% | 0.46% |
| COMMONWEALTH EQUITY SERVICES, LLC | 10/22/2025 | 41.00 K | $127.00 K | 0.00% | 0.45% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 39.28 K | $121.77 K | 100.00% | 0.43% |
| BLACKROCK, INC. | 11/12/2025 | 27.82 K | $86.23 K | 100.00% | 0.31% |
| STATE STREET CORP | 11/14/2025 | 24.92 K | $77.26 K | 110.81% | 0.27% |
| NORTHERN TRUST CORP | 11/14/2025 | 12.51 K | $38.78 K | 0.00% | 0.14% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 6.55 K | $20.73 K | 726.36% | 0.07% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 2.79 K | $8.66 K | 462.17% | 0.03% |
| MORGAN STANLEY | 11/14/2025 | 1.07 K | $3.30 K | 0.00% | 0.01% |
| SIGNATUREFD, LLC | 10/21/2025 | 547 | $1.70 K | 0.00% | 0.01% |
| RONALD BLUE TRUST, INC. | 10/16/2025 | 160 | $496 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 117 | $363 | -14.60% | 0.00% |
| UBS GROUP AG | 11/13/2025 | 102 | $316 | -99.93% | 0.00% |
| KOZAK & ASSOCIATES, INC. | 11/18/2025 | 49 | $117 | 0.00% | 0.00% |
| FMR LLC | 11/13/2025 | 40 | $124 | 100.00% | 0.00% |
| GLOBAL RETIREMENT PARTNERS, LLC | 10/21/2025 | 23 | $71 | 0.00% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 1 | $3 | 100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Vivos Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 26 institutional investors and hedge funds held shares of Vivos Therapeutics, Inc.. The most heavily invested institutionals were:
Connective Capital Management, LLC: 200,000
Strategic Wealth Investment Group, LLC: 100,000
VANGUARD GROUP INC: 91,461
GEODE CAPITAL MANAGEMENT, LLC: 53,289
B. Riley Wealth Advisors, Inc.: 43,531
DRW Securities, LLC: 41,466
7.56% of Vivos Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 735.83 K shares in the last 24 months. This purchase volume represents approximately $2.35 M in transactions.